Flexcin Side Effects

Flexcin represents a nutritional supplement that minimizes pain in joints. Its formula contains cetyl myristoleate, which cushions and lubricates the joints, and methyl sulfonyl methane, which tends to reduce inflammation around the articulations and reduce muscle pains. This product also includes sulphate potassium, glucosamine, bromelain, boron and collagen type 2. This supplement is frequently recommended to individuals suffering from arthritis or other forms of joint stiffness, including pain management for gout.
  1. Side Effects

    • Mild gastrointestinal discomfort may result from the consumption of Flexcin. This includes feelings of nausea or onset of diarrhea that may be caused by the glucosamine and the methyl sulfonyl methane present in Flexcin. Women experiencing menopause may have more intense hot flashes and night sweats from the boron in the formulation.

    Allergies

    • Some elements in Flexcin may cause allergies. For example, individuals who react to shellfish may have allergic reactions to glucosamine present in this supplement. Similarly, patients with allergic reactions to pineapples, olive pollen or honeybee stings should avoid this formulation because of the bromelain in the product. It is best to consult a doctor before taking Flexcin as the medication may interact with three dozen vitamins and minerals and diminish its effects or create discomfort.

    Impediments

    • The manufacturer of Flexcin states that significant relief from joint pain typically appears within 30 to 45 days after daily consumption. Some food may slow down the effects of this supplement. Caffeine and alcohol impedes the processing of the drug. Similarly, steroids will challenge the liver and impair the effects of Flexcin. The manufacturer recommends avoiding smoking, consumption of refined sugars, carbonated beverages, citrus juices and high fat items to maximize Flexcin's effectiveness.

    Safety

    • Flexcin represents a nutritional supplement, not a prescribed medication, and therefore does not require Food and Drug Administration approval. It has not been formally tested for consumer safety. The supplement is manufactured in an FDA-approved facility, however, meaning the plant follows strict standards of quality control.

    Clinical Trials

    • Flexcin has not been tested in clinical trials in its current formulation. However, cetyl myristoleate, its prime ingredient, was evaluated in the mid-1990s as a treatment for joint pain. The first 382-subject study, conducted by Dr. H. Siemandi, showed an improvement of joint stiffness in about 70 percent of the subjects. No side effect caused patients to withdraw from the trial. Only seven patients stopped the treatment and they did so because of their inability to refrain from alcohol or nicotine consumption.

      The second study, led by the San Diego Clinic Immunological Center, investigated optimal dosage for treatment and resulted in similar outcomes.

Arthritis - Related Articles